{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:32:05Z","timestamp":1783114325569,"version":"3.54.6"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Human Papilloma Virus type 16 (HPV-16) is highly oncogenic with the E6 and E7 oncogenes playing crucial roles in the pathogenesis of HPV-related cervical carcinogenesis. Targeting these oncoproteins with specific inhibitors offers a promising approach for therapeutic intervention. This study aimed to identify potential inhibitors of the HPV-16 E6 and E7 oncoproteins through an in silico approach, providing a foundation for the development of targeted therapies against HPV associated malignancies. We performed virtual screening on a library of 1000 compounds to identify promising candidates. Subsequent molecular docking studies were conducted to assess the binding affinities of the promising candidates. The top-scoring compounds for oncoproteins were then subjected to molecular dynamics simulations to evaluate their stability and interaction profiles. The virtual screening identified 14 promising candidates followed by docking studies. Among these Galangin was identified as a promising inhibitor for the E6 oncogene, while Neoechinulin showed potential as an inhibitor of the E7 oncogene. Our findings suggest Galangin and Neoechinulin with high potential as therapeutic inhibitors of HPV-16 E6 and E7 oncogenes respectively. These inhibitors could contribute significantly to the development of targeted therapies against HPV associated malignancies. However, further in vitro and in vivo investigations are required to use these phytochemicals as antiviral agents against HPV-16.<\/jats:p>","DOI":"10.1371\/journal.pone.0323595","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:25:37Z","timestamp":1761585937000},"page":"e0323595","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer"],"prefix":"10.1371","volume":"20","author":[{"given":"Saima","family":"Younas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaryab Ikram","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muzzammel","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2182-0582","authenticated-orcid":true,"given":"Hafiz Muhammad","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7776-6686","authenticated-orcid":true,"given":"Shahina","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"pone.0323595.ref001","doi-asserted-by":"crossref","first-page":"127751","DOI":"10.1016\/j.molstruc.2020.127751","article-title":"Isolation of hesperetin-A flavonoid from Cordia sebestena flower extract through antioxidant assay guided method and its antibacterial, anticancer effect on cervical cancer via in vitro and in silico molecular docking studies","volume":"1207","author":"S Prakash","year":"2020","journal-title":"J Mol Struct"},{"issue":"2","key":"pone.0323595.ref002","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10967-020-07385-1","article-title":"Molecular docking and preliminary bioevaluation of 99mTc-Thiadiazuron as a novel potential agent for cervical cancer imaging","volume":"326","author":"HA Shamsel-Din","year":"2020","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"pone.0323595.ref003","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11030-022-10429-1","article-title":"Unraveling the molecular mechanism of l-menthol against cervical cancer based on network pharmacology, molecular docking and in vitro analysis","volume":"27","author":"H Sidhu","year":"2023","journal-title":"Mol Divers"},{"issue":"4","key":"pone.0323595.ref004","article-title":"Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer","volume":"17","author":"P D S","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"pone.0323595.ref005","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s12010-023-04608-5","article-title":"Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-\u03b21 Potential Inhibitors to Curtail Cervical Cancer Progression","volume":"196","author":"PK Poleboyina","year":"2024","journal-title":"Appl Biochem Biotechnol"},{"issue":"1","key":"pone.0323595.ref006","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41598-022-05995-1","article-title":"Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain","volume":"12","author":"LE Araujo-Arcos","year":"2022","journal-title":"Sci Rep"},{"issue":"02","key":"pone.0323595.ref007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.24036\/sainstek\/vol1-iss02\/7","article-title":"Molecular Docking Study of Nigella sativa Bioactive Compound as E6 Inhibitor Against Human Papillomavirus (HPV) Infection","volume":"1","author":"AAA Murtadlo","year":"2022","journal-title":"SAISNTEK"},{"issue":"1","key":"pone.0323595.ref008","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/s41467-019-10246-5","article-title":"Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus","volume":"10","author":"J Zhao","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"pone.0323595.ref009","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/v13101892","article-title":"The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis","volume":"13","author":"O Basukala","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"pone.0323595.ref010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1515\/hsz-2019-0408","article-title":"Human papillomavirus oncoproteins and post-translational modifications: generating multifunctional hubs for overriding cellular homeostasis","volume":"401","author":"O Basukala","year":"2020","journal-title":"Biol Chem"},{"issue":"5","key":"pone.0323595.ref011","first-page":"672","article-title":"PI3K\/AKT\/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications","volume":"12","author":"F Aguayo","year":"2023","journal-title":"Biology (Basel)"},{"issue":"1","key":"pone.0323595.ref012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13353-024-00883-y","article-title":"HPV-driven oncogenesis-much more than the E6 and E7 oncoproteins","volume":"66","author":"J Janiszewska","year":"2025","journal-title":"J Appl Genet"},{"issue":"9","key":"pone.0323595.ref013","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/vaccines10091452","article-title":"In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein","volume":"10","author":"M Soumia","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"pone.0323595.ref014","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1517\/13543784.2015.1099628","article-title":"An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia","volume":"24","author":"L Hampson","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"pone.0323595.ref015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/cancers13050949","article-title":"HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins","volume":"13","author":"S Park","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0323595.ref016","first-page":"91","article-title":"Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis","volume":"1845","author":"AC de Freitas","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"pone.0323595.ref017","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0323595.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"P Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0323595.ref019","doi-asserted-by":"crossref","first-page":"27012","DOI":"10.1289\/EHP9341","article-title":"STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity","volume":"130","author":"JVB Borba","year":"2022","journal-title":"Environ Health Perspect"},{"key":"pone.0323595.ref020","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Y Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"pone.0323595.ref021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"pone.0323595.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3407091","article-title":"Determination of the Lipophilicity of Ibuprofen, Naproxen, Ketoprofen, and Flurbiprofen with Thin-Layer Chromatography","volume":"2019","author":"A Czyrski","year":"2019","journal-title":"Journal of Chemistry"},{"key":"pone.0323595.ref023","first-page":"731","volume-title":"Computer-aided prediction of pharmacokinetic (ADMET) properties, in Dosage form design parameters","author":"B Chandrasekaran","year":"2018"},{"key":"pone.0323595.ref024","doi-asserted-by":"crossref","DOI":"10.1016\/B0-08-045044-X\/00147-4","article-title":"In silico prediction of oral bioavailability","volume-title":"Comprehensive medicinal chemistry II ADME Tox approaches","author":"J Turner","year":"2007"},{"issue":"20","key":"pone.0323595.ref025","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1080\/07391102.2022.2155699","article-title":"Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic \u03b1-amylase","volume":"41","author":"B Kikiowo","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"11","key":"pone.0323595.ref026","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules","volume":"11","author":"A Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"2","key":"pone.0323595.ref027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/1735-5362.335177","article-title":"In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors","volume":"17","author":"N Razzaghi-Asl","year":"2022","journal-title":"Res Pharm Sci"},{"key":"pone.0323595.ref028","doi-asserted-by":"crossref","first-page":"105234","DOI":"10.1016\/j.bioorg.2021.105234","article-title":"Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R\/T790M Non-Small-Cell lung cancer (NSCLC)","volume":"115","author":"R Pawara","year":"2021","journal-title":"Bioorg Chem"},{"key":"pone.0323595.ref029","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lfs.2018.10.048","article-title":"Structural and functional aspects of P-glycoprotein and its inhibitors","volume":"214","author":"S Mollazadeh","year":"2018","journal-title":"Life Sci"},{"key":"pone.0323595.ref030","article-title":"Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions","author":"J-D Mar\u00e9chal","year":"2008","journal-title":"Br J Pharmacol"},{"key":"pone.0323595.ref031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1081\/DMR-120001387","article-title":"Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes","volume":"34","author":"PF Hollenberg","year":"2002","journal-title":"Drug Metab Rev"},{"key":"pone.0323595.ref032","article-title":"In silico pharmacokinetics and molecular docking studies of lead compounds derived from Diospyros mespiliformis","author":"AH Ahmed","year":"2019","journal-title":"PharmaTutor"},{"issue":"3","key":"pone.0323595.ref033","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/cts.12542","article-title":"Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People","volume":"11","author":"BA Khan","year":"2018","journal-title":"Clin Transl Sci"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:25:44Z","timestamp":1761585944000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323595"}},"subtitle":[],"editor":[{"given":"Prakash","family":"Palaniswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0323595","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}